Literature DB >> 9727569

Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen.

D W Notermans1, J Goudsmit, S A Danner, F de Wolf, A S Perelson, J Mittler.   

Abstract

OBJECTIVES AND
DESIGN: The dynamics uf viral decline following the initiation of antiretroviral treatment were studied in 29 HIV-1-infected patients participating in a two-arm trial comparing immediate (group A: ritonavir, zidovudine and lamivudine) and delayed (group B: ritonavir supplemented by zidovudine and lamivudine on day 21) triple therapy. Parameters underlying viral dynamics were estimated using mathematical models tailored to these treatment protocols.
RESULTS: The decline in plasma HIV-1 density between day 0 and 21 was steeper in group A (-2.27+/- 0.46 log10) than group B (-1.87+/-0.56 log10). In a subset of patients amenable to full mathematical analysis, a short-lived productively infected cell compartment (producing approximately 97% of total virions) decayed with a half-life of 1.0-2.5 days, whereas a long-lived infected cell compartment decayed with a half-life of 18.8-32.8 days. Estimates for the time for the elimination of virus from these two cell populations ranged from 474 to 802 days. The rate of loss of productively infected CD4+ T cells was positively correlated with baseline viral load in group A and in the combined dataset.
CONCLUSIONS: These results suggest that HIV-infected cell populations may have a faster turnover in patients with higher viral loads due to higher infection rate parameters, higher rates of virus production, or lower virus clearance rates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727569     DOI: 10.1097/00002030-199812000-00010

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  30 in total

1.  Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy.

Authors:  N M Ferguson; F deWolf; A C Ghani; C Fraser; C A Donnelly; P Reiss; J M Lange; S A Danner; G P Garnett; J Goudsmit; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  HIV-1 dynamics revisited: biphasic decay by cytotoxic T lymphocyte killing?

Authors:  R A Arnaout; M A Nowak; D Wodarz
Journal:  Proc Biol Sci       Date:  2000-07-07       Impact factor: 5.349

3.  Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy.

Authors:  W S Hlavacek; N I Stilianakis; D W Notermans; S A Danner; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

4.  Using mathematical modeling and control to develop structured treatment interruption strategies for HIV infection.

Authors:  Eric S Rosenberg; Marie Davidian; H Thomas Banks
Journal:  Drug Alcohol Depend       Date:  2007-02-05       Impact factor: 4.492

5.  A DYNAMIC BAYESIAN NONLINEAR MIXED-EFFECTS MODEL OF HIV RESPONSE INCORPORATING MEDICATION ADHERENCE, DRUG RESISTANCE AND COVARIATES().

Authors:  Yangxin Huang; Hulin Wu; Jeanne Holden-Wiltse; Edward P Acosta
Journal:  Ann Appl Stat       Date:  2011       Impact factor: 2.083

6.  Segmental modeling of changing viral load to assess drug resistance in HIV infection.

Authors:  H Liang
Journal:  Stat Methods Med Res       Date:  2007-08       Impact factor: 3.021

7.  Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence.

Authors:  Hulin Wu; Yangxin Huang; Edward P Acosta; Jeong-Gun Park; Song Yu; Susan L Rosenkranz; Daniel R Kuritzkes; Joseph J Eron; Alan S Perelson; John G Gerber
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-04-01       Impact factor: 2.745

8.  Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline.

Authors:  J Michael Kilby; Ha Youn Lee; J Darren Hazelwood; Anju Bansal; R Patterson Bucy; Michael S Saag; George M Shaw; Edward P Acosta; Victoria A Johnson; Alan S Perelson; Paul A Goepfert
Journal:  AIDS       Date:  2008-05-11       Impact factor: 4.177

9.  Parameter Estimation for Differential Equation Models Using a Framework of Measurement Error in Regression Models.

Authors:  Hua Liang; Hulin Wu
Journal:  J Am Stat Assoc       Date:  2008-12-01       Impact factor: 5.033

10.  CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.

Authors:  Nichole R Klatt; Emi Shudo; Alex M Ortiz; Jessica C Engram; Mirko Paiardini; Benton Lawson; Michael D Miller; James Else; Ivona Pandrea; Jacob D Estes; Cristian Apetrei; Joern E Schmitz; Ruy M Ribeiro; Alan S Perelson; Guido Silvestri
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.